Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry

Camilla Hesse, Carl L. Nilsson, Kaj Blennow, Pia Davidsson

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Apolipoprotein E (apoE) was isolated from human cerebrospinal fluid (CSF) from control individuals and patients with Alzheimer's disease (AD). The purification was performed with preparative two-dimensional electrophoresis (2-DE), involving liquid-phase isoelectric focusing (IEF) in the Rotofor cell in combination with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroelution in the Mini Whole Gel Eluter. ApoE was characterized by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) analysis of tryptic digests. The known change of Cys to Arg in position 112 of the apoE4 isoform was identified. This was detected in CSF fromAD patients, reflecting the increased frequency of the apoE4 allele in this population. This peptide was not detected in CSF samples from healty control individuals. The use of this rapid electrophoretic separation in proteomic studies of CSF proteins provides single proteins, such as apoE, of high purity in yields sufficient for characterization by MALDI-TOF-MS. Characterization of proteins and their modifications (amino acid substitutions, glycosylation or phosphorylation) in CSF will be a useful tool in the investigation of the pathophysiology of brain disorders such as AD.

Original languageEnglish (US)
Pages (from-to)1834-1837
Number of pages4
JournalElectrophoresis
Volume22
Issue number9
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Apolipoprotein E4
Cerebrospinal fluid
Electrophoresis
Ionization
Mass spectrometry
Cerebrospinal Fluid
Desorption
Mass Spectrometry
Protein Isoforms
Lasers
Apolipoproteins E
Alzheimer Disease
Glycosylation
Cerebrospinal Fluid Proteins
Phosphorylation
Isoelectric Focusing
Brain Diseases
Amino Acid Substitution
Gene Frequency
Sodium Dodecyl Sulfate

Keywords

  • Apolipoprotein E
  • Cerebrospinal fluid
  • Characterization
  • Matrix assisted laser desorption/ionization-time of flight-mass spectrometry
  • Preparative two-dimensional electrophoresis

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry. / Hesse, Camilla; Nilsson, Carl L.; Blennow, Kaj; Davidsson, Pia.

In: Electrophoresis, Vol. 22, No. 9, 2001, p. 1834-1837.

Research output: Contribution to journalArticle

@article{841fed8c7800469196696805c78659e6,
title = "Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry",
abstract = "Apolipoprotein E (apoE) was isolated from human cerebrospinal fluid (CSF) from control individuals and patients with Alzheimer's disease (AD). The purification was performed with preparative two-dimensional electrophoresis (2-DE), involving liquid-phase isoelectric focusing (IEF) in the Rotofor cell in combination with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroelution in the Mini Whole Gel Eluter. ApoE was characterized by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) analysis of tryptic digests. The known change of Cys to Arg in position 112 of the apoE4 isoform was identified. This was detected in CSF fromAD patients, reflecting the increased frequency of the apoE4 allele in this population. This peptide was not detected in CSF samples from healty control individuals. The use of this rapid electrophoretic separation in proteomic studies of CSF proteins provides single proteins, such as apoE, of high purity in yields sufficient for characterization by MALDI-TOF-MS. Characterization of proteins and their modifications (amino acid substitutions, glycosylation or phosphorylation) in CSF will be a useful tool in the investigation of the pathophysiology of brain disorders such as AD.",
keywords = "Apolipoprotein E, Cerebrospinal fluid, Characterization, Matrix assisted laser desorption/ionization-time of flight-mass spectrometry, Preparative two-dimensional electrophoresis",
author = "Camilla Hesse and Nilsson, {Carl L.} and Kaj Blennow and Pia Davidsson",
year = "2001",
doi = "10.1002/1522-2683(200105)22:9<1834::AID-ELPS1834>3.0.CO;2-V",
language = "English (US)",
volume = "22",
pages = "1834--1837",
journal = "Electrophoresis",
issn = "0173-0835",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry

AU - Hesse, Camilla

AU - Nilsson, Carl L.

AU - Blennow, Kaj

AU - Davidsson, Pia

PY - 2001

Y1 - 2001

N2 - Apolipoprotein E (apoE) was isolated from human cerebrospinal fluid (CSF) from control individuals and patients with Alzheimer's disease (AD). The purification was performed with preparative two-dimensional electrophoresis (2-DE), involving liquid-phase isoelectric focusing (IEF) in the Rotofor cell in combination with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroelution in the Mini Whole Gel Eluter. ApoE was characterized by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) analysis of tryptic digests. The known change of Cys to Arg in position 112 of the apoE4 isoform was identified. This was detected in CSF fromAD patients, reflecting the increased frequency of the apoE4 allele in this population. This peptide was not detected in CSF samples from healty control individuals. The use of this rapid electrophoretic separation in proteomic studies of CSF proteins provides single proteins, such as apoE, of high purity in yields sufficient for characterization by MALDI-TOF-MS. Characterization of proteins and their modifications (amino acid substitutions, glycosylation or phosphorylation) in CSF will be a useful tool in the investigation of the pathophysiology of brain disorders such as AD.

AB - Apolipoprotein E (apoE) was isolated from human cerebrospinal fluid (CSF) from control individuals and patients with Alzheimer's disease (AD). The purification was performed with preparative two-dimensional electrophoresis (2-DE), involving liquid-phase isoelectric focusing (IEF) in the Rotofor cell in combination with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroelution in the Mini Whole Gel Eluter. ApoE was characterized by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) analysis of tryptic digests. The known change of Cys to Arg in position 112 of the apoE4 isoform was identified. This was detected in CSF fromAD patients, reflecting the increased frequency of the apoE4 allele in this population. This peptide was not detected in CSF samples from healty control individuals. The use of this rapid electrophoretic separation in proteomic studies of CSF proteins provides single proteins, such as apoE, of high purity in yields sufficient for characterization by MALDI-TOF-MS. Characterization of proteins and their modifications (amino acid substitutions, glycosylation or phosphorylation) in CSF will be a useful tool in the investigation of the pathophysiology of brain disorders such as AD.

KW - Apolipoprotein E

KW - Cerebrospinal fluid

KW - Characterization

KW - Matrix assisted laser desorption/ionization-time of flight-mass spectrometry

KW - Preparative two-dimensional electrophoresis

UR - http://www.scopus.com/inward/record.url?scp=70449628747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449628747&partnerID=8YFLogxK

U2 - 10.1002/1522-2683(200105)22:9<1834::AID-ELPS1834>3.0.CO;2-V

DO - 10.1002/1522-2683(200105)22:9<1834::AID-ELPS1834>3.0.CO;2-V

M3 - Article

VL - 22

SP - 1834

EP - 1837

JO - Electrophoresis

JF - Electrophoresis

SN - 0173-0835

IS - 9

ER -